行情

FOLD

FOLD

爱美医疗
NASDAQ

实时行情|Nasdaq Last Sale

15.55
0.00
0.00%
盘后: 15.55 0 0.00% 16:42 07/02 EDT
开盘
15.80
昨收
15.55
最高
15.86
最低
15.49
成交量
149.67万
成交额
--
52周最高
15.91
52周最低
6.25
市值
40.07亿
市盈率(TTM)
-12.0012
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测FOLD价格均价为18.54,最高价位31.00,最低价为11.00。

EPS

FOLD 新闻

更多
Two Patients Die in Audentes Gene Therapy Study, Heightening Concerns Over High-dose Treatments
-Stat News https://www.statnews.com/2020/06/28/two-patients-die-audentes-gene-therapy-study/
Stat News · 6天前
Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.9%
Zacks · 06/22 14:23
Amicus Therapeutics: 2 Potential Blockbusters Make This Stock Worth Considering
Seeking Alpha - Article · 06/18 13:45
BTIG Initiates Coverage On Amicus Therapeutics with Buy Rating, Announces Price Target of $19
BTIG analyst Dae Gon Ha initiates coverage on Amicus Therapeutics (NASDAQ:FOLD) with a Buy rating and announces Price Target of $19.
Benzinga · 06/17 10:25
Protalix Undervalued Due To Ghost Of Shire, Upside On Fabry Approval Significant
Seeking Alpha - Article · 06/09 12:23
Amicus Therapeutics, Inc. (FOLD): Hedge Funds Folding Their Hands
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are
Insider Monkey · 06/08 07:38
Why Is Amicus Therapeutics (FOLD) Up 10.9% Since Last Earnings Report?
Zacks · 06/06 16:31
Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
CRANBURY, N.J., June 04, 2020 -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside.
GlobeNewswire · 06/04 11:00

所属板块

生物技术和医学研究
+0.67%
制药与医学研究
+0.61%

热门股票

代码
价格
涨跌幅

FOLD 简况

Amicus Therapeutics, Inc.是一家生物制药公司。该公司专注于发现和开发治疗各种罕见疾病的疗法。其先导候选产品,migalastat HCl Galafold)是一种用于治疗法布瑞氏症的口服小分子药理伴侣。法布瑞氏症是一种溶酶体贮积症(LSD)。它已完成migalastat单一治疗的两个第三阶段全球注册研究(研究011和研究012)。它还参与局部乳膏(SD-101)的III期临床开发。SD-101用于治疗遗传性结缔组织疾病,表皮溶解水疱症。它还启动了庞培氏病患者的临床研究,以研究其由ATB200构成的治疗范例。庞培氏病是一种LSD。ATB200是一个精心设计的重组类酸性α-葡萄糖苷酶。ATB200通过优化的碳水化合物结构加强吸收,以及与AT2221共同作用以提高活性和稳定性。
展开

微牛提供Amicus Therapeutics, Inc.(NASDAQ-FOLD)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的FOLD股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易FOLD股票基本功能。